HETEROPLASIA

HETEROPLASIA was reported 39 times

HETEROPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 1 0.0002
1 Pyrimidine Synthesis Inhibitor [EPC] 5 0.0001
2 Bile Acid Sequestrant [EPC] 1 0.0001
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 8 0.0001
4 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1 0.0001
5 Cardiac Glycoside [EPC] 2 0.0000
6 Selective T Cell Costimulation Modulator [EPC] 3 0.0000
7 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
8 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
9 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
10 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
11 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
12 Janus Kinase Inhibitor [EPC] 2 0.0000
13 Integrin Receptor Antagonist [EPC] 1 0.0000
14 Anti-IgE [EPC] 1 0.0000
15 Loop Diuretic [EPC] 5 0.0000
16 Factor Xa Inhibitor [EPC] 3 0.0000
17 Partial Opioid Agonist [EPC] 1 0.0000
18 Aminosalicylate [EPC] 1 0.0000
19 5-alpha Reductase Inhibitor [EPC] 1 0.0000
20 Parathyroid Hormone Analog [EPC] 1 0.0000
21 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
22 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
23 Kinase Inhibitor [EPC] 2 0.0000
24 GLP-1 Receptor Agonist [EPC] 1 0.0000
25 Insulin Analog [EPC] 1 0.0000
26 Atypical Antipsychotic [EPC] 1 0.0000
27 Thalidomide Analog [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000